Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
12 "Cancer survivors"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Associations of Financial Toxicity with Employment Concerns and Cancer-Related Distress: A Cross-Sectional Survey among Korean Working-Age Cancer Survivors
Hyun-Ju Seo, Dal-Lae Jin, Young Ae Kim, Su Jung Lee, Seok-Jun Yoon
Received January 24, 2024  Accepted December 2, 2024  Published online December 3, 2024  
DOI: https://doi.org/10.4143/crt.2024.090    [Accepted]
AbstractAbstract PDF
Purpose
Although South Korea’s health insurance has a co-payment-decreasing policy for cancer survivors, information on the extent of financial toxicity and its related factors is limited. We assessed the level of financial toxicity and the association of high levels of financial toxicity with employment concerns after diagnosis and cancer-related distress in working-age cancer survivors.
Materials and Methods
A cross-sectional study was conducted. Study participants were recruited from the National Cancer Survivorship Center between November and December 2022. Financial burden was assessed using the Korean version of the Comprehensive Score for Financial Toxicity, and cancer-related distress was measured using the NCCN Distress Thermometer. Multivariate logistic regression analyses were used to explore the associations between high financial toxicity, cancer-related distress, and changes in employment status after cancer diagnosis.
Results
Of 1,403 working-age cancer survivors, approximately 62% reported high levels of financial distress. Survivors reporting early retirement and taking time off work with the intent to return were more likely to report high financial toxicity (adjusted OR 1.69, 95% CI 1.14-2.5; and adjusted OR 2.82, 95% CI 1.24-6.43, respectively) than those with a full-time or part-time job. Moreover, cancer survivors with high distress levels were more likely to report high financial toxicity than those with low distress levels (adjusted OR 4.36, 95% CI 3.17-5.99).
Conclusion
High financial toxicity is associated with adverse employment concerns and cancer-related distress among working-age cancer survivors. Therefore, developing cancer survivorship interventions within the healthcare system is necessary to ensure improvements in financial well-being.

Citations

Citations to this article as recorded by  
  • Chronic Disease and Future Perceptions of Financial Control
    Victoria H. Davis, Guanghao Zhang, Minal R. Patel
    Medical Care.2025;[Epub]     CrossRef
  • 296 View
  • 39 Download
  • 1 Crossref
Close layer
Weight Change after Cancer Diagnosis and Risk of Diabetes Mellitus: A Population-Based Nationwide Study
Hye Yeon Koo, Kyungdo Han, Mi Hee Cho, Wonyoung Jung, Jinhyung Jung, In Young Cho, Dong Wook Shin
Received June 25, 2024  Accepted August 28, 2024  Published online August 29, 2024  
DOI: https://doi.org/10.4143/crt.2024.586    [Epub ahead of print]
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Cancer survivors are at increased risk of diabetes mellitus (DM). Additionally, the prevalence of obesity, which is also a risk factor for DM, is increasing in cancer survivors. We investigated the associations between weight change after cancer diagnosis and DM risk.
Materials and Methods
This retrospective cohort study used data from the Korean National Health Insurance Service. Participants who were newly diagnosed with cancer from 2010 to 2016 and received national health screening before and after diagnosis were included and followed until 2019. Weight change status after cancer diagnosis was categorized into four groups: sustained normal weight, obese to normal weight, normal weight to obese, or sustained obese. Cox proportional hazard analyses were performed to examine associations between weight change and DM.
Results
The study population comprised 264,250 cancer survivors. DM risk was highest in sustained obese (adjusted hazard ratios [aHR], 2.17; 95% confidence interval [CI], 2.08 to 2.26), followed by normal weight to obese (aHR, 1.66; 95% CI, 1.54 to 1.79), obese to normal weight (aHR, 1.29; 95% CI, 1.21 to 1.39), and then sustained normal weight group (reference). In subgroup analyses according to cancer type, most cancers showed the highest risks in sustained obese group.
Conclusion
Obesity at any time point was related to increased DM risk, presenting the highest risk in cancer survivors with sustained obesity. Survivors who changed from obese to normal weight had lower risk than survivors with sustained obesity. Survivors who changed from normal weight to obese showed increased risk compared to those who sustained normal weight. Our finding supports the significance of weight management among cancer survivors.

Citations

Citations to this article as recorded by  
  • Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study
    MI Hee Cho, Jinhyung Jung, Hye Yeon Koo, Wonyoung Jung, Kyungdo Han, In Young Cho, Dong Wook Shin
    Diabetes & Metabolism.2025; 51(1): 101604.     CrossRef
  • 492 View
  • 49 Download
  • 1 Crossref
Close layer
Breast cancer
Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer
Thi Xuan Mai Tran, Soyeoun Kim, Chihwan Cha, Boyoung Park
Cancer Res Treat. 2024;56(2):522-530.   Published online October 30, 2023
DOI: https://doi.org/10.4143/crt.2023.729
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
This study assessed the temporal trends of uptake of national general health and cancer screening among women with breast cancer in Korea between 2009 and 2016.
Materials and Methods
We retrospectively analyzed the claims data from the Korean National Health Insurance Service database. Participants included 101,403 breast cancer patients diagnosed between 2009 and 2016. Information on participation in national screening programs, including breast cancer screening, general health, and gastric, colorectal, and cervical cancers, up to 2020 was collected. Screening participation rates within the first 2 and 5 years postdiagnosis were calculated by diagnosis year and fitted with joinpoint regression models to assess temporal trends.
Results
Overall, the participation rate in breast cancer screening within 2 years postdiagnosis increased from 10.9% to 14.0% from 2009-2016, with an annual percentage change (APC) of 3.7% (p < 0.05). The participation rate in breast cancer screening was lower than that in general health checkup and screening for other cancers within 2 and 5 years postdiagnosis. A steady increase in screening trends was also observed for general health, gastric, colorectal, and cervical cancers, with APC of 5.3%, 5.7%, 6.9%, and 7.6% in the 2-year postdiagnosis rate, and APC of 3.6%, 3.7%, 3.7%, and 4.4% in 5-year postdiagnosis rate, respectively. The screening rate was highest among age groups 50-59 and 60-69 in 2009 and significant upward trends were observed in all age groups for general health checkup and gastric, colorectal, and cervical cancer screening.
Conclusion
Among female breast cancer survivors in Korea, the uptake rate of screenings for general health and various cancers, including breast, gastric, colorectal, and cervical cancers, has shown a gradual increase in recent years.

Citations

Citations to this article as recorded by  
  • Identifying potential medical aid beneficiaries using machine learning: A Korean Nationwide cohort study
    Junmo Kim, Su Hyun Park, Hyesu Lee, Su Kyoung Lee, Jihye Kim, Suhyun Kim, Yong Jin Kwon, Kwangsoo Kim
    International Journal of Medical Informatics.2025; 195: 105775.     CrossRef
  • Screening Adherence for Second Primary Malignancies in Breast Cancer Survivors: Behaviors, Facilitators, and Barriers to Enhance Quality Care
    Fernanda Mesa-Chavez, Misael Salazar-Alejo, Cynthia Villarreal-Garza
    Seminars in Oncology.2024; 51(5-6): 156.     CrossRef
  • 3,337 View
  • 91 Download
  • 2 Web of Science
  • 2 Crossref
Close layer
Pediatric cancer
Gonadal Function in Female Adolescent and Young Adult Survivors of Childhood Cancer
Hye Young Jin, Jun Ah Lee, Meerim Park, Hyeon Jin Park
Cancer Res Treat. 2023;55(3):992-1000.   Published online January 31, 2023
DOI: https://doi.org/10.4143/crt.2022.1518
AbstractAbstract PDFPubReaderePub
Purpose
Childhood cancer survivors (CCSs) are at risk for premature ovarian insufficiency (POI). The aim of this study is to evaluate ovarian function and associated health outcomes in female adolescent and young adult survivors of childhood cancer.
Materials and Methods
Sixty-nine female CCSs were enrolled. Medical records of CCSs were retrospectively reviewed. The subjects were categorized into three groups according to follicular stimulating hormone (FSH) levels (cutoff, 12, 40 IU/L). Anti-müllerian hormone (AMH) level less than 1 ng/mL was considered low AMH level.
Results
Of 69 subjects, 14 (20.3%) had POI and 14 (20.3%) had FSH levels between 12 and 40 IU/L. Forty-one of 69 (59.4%) had normal FSH levels. Pelvic irradiation and stem cell transplantation (SCT) were more frequently performed in subjects with POI (p=0.001 and p < 0.001). AMH levels were remarkably low when FSH levels were over 12 IU/L (p < 0.001). In multivariate analysis, cyclophosphamide equivalent dose and SCT were significant treatment factors for developing low AMH levels (p=0.005 and p=0.002, respectively). Total, low-density lipoprotein cholesterol and triglyceride were significantly different in three groups according to FSH levels (p=0.047, p=0.030, and p=0.045). Z-score of femur neck bone mineral density was significantly reduced when FSH levels were increased (p=0.011).
Conclusion
Gonadal dysfunction is common in CCSs. Gonadal function was associated with a few treatment factors known to increase the risk of POI. Regular monitoring of gonadal function is needed for better health outcomes.

Citations

Citations to this article as recorded by  
  • Systematic Review of the Gonadotoxicity and Risk of Infertility of Soft Tissue Sarcoma Chemotherapies in Pre- and Postpubertal Females and Males
    Marcel Steinmann, Anita Rietschin, Flavia Pagano, Tanya Karrer, Attila Kollár, Susanna Weidlinger, Michael von Wolff
    Journal of Adolescent and Young Adult Oncology.2024; 13(6): 803.     CrossRef
  • Bone Mineral Density in Survivors of Childhood Cancer: A Meta-Analysis
    Lilly Velentza, Panagiotis Filis, Mari Wilhelmsson, Per Kogner, Nikolas Herold, Lars Sävendahl
    Pediatrics.2024;[Epub]     CrossRef
  • 3,338 View
  • 166 Download
  • 2 Web of Science
  • 2 Crossref
Close layer
Breast cancer
Epidemiology of Second Non-breast Primary Cancers among Survivors of Breast Cancer: A Korean Population–Based Study by the SMARTSHIP Group
Haeyoung Kim, Su SSan Kim, Ji Sung Lee, Jae Sun Yoon, Hyun Jo Youn, Hyukjai Shin, Jeong Eon Lee, Se Kyung Lee, Il Yong Chung, So-Youn Jung, Young Jin Choi, Jihyoung Cho, Sang Uk Woo, Korean Breast Cancer Society
Cancer Res Treat. 2023;55(2):580-591.   Published online December 27, 2022
DOI: https://doi.org/10.4143/crt.2022.410
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
This study aimed to evaluate the incidence and prognosis of second non-breast primary cancer (SNBPC) among Korean survivors of breast cancer.
Materials and Methods
Data from the Korean National Health Insurance Service were searched to identify women who received curative surgery for initial breast cancer (IBC) between 2003 and 2008 (n=64,340). Among them, patients with the following characteristics were excluded: other cancer diagnosis before IBC (n=10,866), radiotherapy before IBC (n=349), absence of data on sex or age (n=371), or male (n=248). Accordingly, data of 52,506 women until December 2017 were analyzed. SNBPC was defined as a newly diagnosed SNBPC that occurred 5 years or more after IBC diagnosis.
Results
The median follow-up time of all patients was 12.13 years. SNBPC was developed in 3,084 (5.87%) women after a median of 7.61 years following IBC diagnosis. The 10-year incidence of SNBPC was 5.78% (95% confidence interval [CI], 5.56 to 6.00). Higher SNBPC incidence was found in survivors with the following factors: old age at IBC diagnosis, low household income, and receiving combined chemotherapy with endocrine therapy, whereas receiving radiotherapy was related to a lower incidence of SNBPC (hazard ratio, 0.89; p < 0.01). Among the patients with SNBPC, the 5-year survival rate was 62.28% (95% CI, 65.53 to 69.02).
Conclusion
Approximately 5% of breast cancer survivors developed SNBPC within 10 years after IBC diagnosis. The risk of SNBPC was associated with patient’s age at IBC diagnosis, income level, and a receipt of systemic treatments.

Citations

Citations to this article as recorded by  
  • Association of radiotherapy for stage I–III breast cancer survivors and second primary malignant cancers: a population-based study
    Jin Shi, Jian Liu, Guo Tian, Daojuan Li, Di Liang, Jun Wang, Yutong He
    European Journal of Cancer Prevention.2024; 33(2): 115.     CrossRef
  • 4,636 View
  • 91 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
General
Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients’ Returning to Work (START): A Multi-center, Randomized Controlled Trial
Danbee Kang, Ka Ryeong Bae, Yeojin Ahn, Nayeon Kim, Seok Jin Nam, Jeong Eon Lee, Se Kyung Lee, Young Mog Shim, Dong Hyun Sinn, Seung Yeop Oh, Mison Chun, Jaesung Heo, Juhee Cho
Cancer Res Treat. 2023;55(2):419-428.   Published online November 8, 2022
DOI: https://doi.org/10.4143/crt.2022.939
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
We developed a comprehensive return to work (RTW) intervention covering physical, psycho-social and practical issues for patients newly diagnosed and evaluated its efficacy in terms of RTW.
Materials and Methods
A multi-center randomized controlled trial was done to evaluate the efficacy of the intervention conducted at two university-based cancer centers in Korea. The intervention program comprised educational material at diagnosis, a face-to-face educational session at completion of active treatment, and three individualized telephone counseling sessions. The control group received other education at enrollment.
Results
At 1-month post-intervention (T2), the intervention group was more likely to be working compared to the control group after controlling working status at diagnosis (65.4% vs. 55.9%, p=0.037). Among patients who did not work at baseline, the intervention group was 1.99-times more likely to be working at T2. The mean of knowledge score was higher in the intervention group compared to the control group (7.4 vs. 6.8, p=0.029). At the 1-year follow-up, the intervention group was 65% (95% confidence interval, 0.78 to 3.48) more likely to have higher odds for having work.
Conclusion
The intervention improved work-related knowledge and was effective in facilitating cancer patients’ RTW.

Citations

Citations to this article as recorded by  
  • Supporting Life Adjustment in Patients With Lung Cancer Through a Comprehensive Care Program: Protocol for a Controlled Before-and-After Trial
    Wonyoung Jung, Alice Ahn, Genehee Lee, Sunga Kong, Danbee Kang, Dongok Lee, Tae Eun Kim, Young Mog Shim, Hong Kwan Kim, Jongho Cho, Juhee Cho, Dong Wook Shin
    JMIR Research Protocols.2024; 13: e54707.     CrossRef
  • A visualized and bibliometric analysis of cancer vocational rehabilitation research using CiteSpace
    Zebing Luo, Xuejia Liu, Chujun Chen
    Work.2024; : 1.     CrossRef
  • Psychosocial Adjustment Experiences Among Nasopharyngeal Carcinoma Survivors
    Jie Jiang, Ming-Hui Yan, Yu-Ying Fan, Jun-E Zhang
    Cancer Nursing.2023;[Epub]     CrossRef
  • 4,499 View
  • 141 Download
  • 2 Web of Science
  • 3 Crossref
Close layer
Breast cancer
Validation of Korean Version of the COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors
Sungkeun Shim, Danbee Kang, Nayeon Kim, Gayeon Han, Jihyun Lim, Hyunsoo Kim, Jeonghyun Park, Mankyung Lee, Jeong Eon Lee, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Jai Min Ryu, Seok Jin Nam, Se Kyung Lee, Juhee Cho
Cancer Res Treat. 2022;54(3):834-841.   Published online October 13, 2021
DOI: https://doi.org/10.4143/crt.2021.784
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Little is known about the impact of financial toxicity in disease-free breast cancer survivors. We aim to validate the COmprehensive Score for financial Toxicity in Korean (COST-K) and evaluate financial toxicity among disease-free breast cancer survivors.
Materials and Methods
We conducted linguistic validation following a standardized methodology recommended by Functional Assessment of Chronic Illness Therapy multilingual translation (FACITtrans). For psychometric validation, we conducted a cross-sectional survey with 4,297 disease-free breast cancer survivors at a tertiary hospital in Seoul, Korea between November 2018 and April 2019. Survivors were asked to complete the COST-K and European Organization for Research and Treatment of Cancer Quality of Life Core 30 (EORTC QLQ-C30) questionnaires. The test-retest reliability, internal consistency, and validity of the COST-K were assessed using standard scale construction techniques.
Results
The COST-K demonstrated good internal consistency, with a Cronbach’s α of 0.81. The test-retest analysis revealed an intraclass correlation coefficient of 0.78. The COST-K had moderate correlation (r=–0.60) with the financial difficulty item of the EORTC QLQ-C30 and week correlation with the items on acute and chronic symptom burdens (nausea/vomiting, –0.18; constipation, –0.14; diarrhea, –0.14), showing good convergent and divergent validity. The median COST-K was 27 (range, 0 to 44; mean±standard deivation [SD], 27.1±7.5) and about 30% and 5% of cancer survivors experienced mild and severe financial toxicity, respectively. Younger age, lower education, lower household income was associated with higher financial toxicity.
Conclusion
The COST-K is a valid and reliable instrument for measuring financial toxicity in disease-free breast cancer survivors. Considering its impact on the health-related quality of life, more studies need to be conducted to evaluate financial toxicity in cancer survivors and design interventions.

Citations

Citations to this article as recorded by  
  • Severity of Financial Toxicity for Patients Receiving Palliative Radiation Therapy
    Jeremy P. Harris, Eric Ku, Garrett Harada, Sophie Hsu, Elaine Chiao, Pranathi Rao, Erin Healy, Misako Nagasaka, Jessica Humphreys, Michael A. Hoyt
    American Journal of Hospice and Palliative Medicine®.2024; 41(6): 592.     CrossRef
  • Financial Toxicity in Radiation Oncology: Impact for Our Patients and for Practicing Radiation Oncologists
    Victoria S. Wu, Xinglei Shen, Janet de Moor, Fumiko Chino, Jonathan Klein
    Advances in Radiation Oncology.2024; 9(3): 101419.     CrossRef
  • Measures of financial toxicity in cancer survivors: a systematic review
    L. B. Thomy, M. Crichton, L. Jones, P. M. Yates, N. H. Hart, L. G. Collins, R. J. Chan
    Supportive Care in Cancer.2024;[Epub]     CrossRef
  • Validation of the COmprehensive Score for Financial Toxicity (COST) in Vietnamese patients with cancer
    Binh Thang Tran, Dinh Duong Le, Thanh Gia Nguyen, Minh Tu Nguyen, Minh Hanh Nguyen, Cao Khoa Dang, Dinh Trung Tran, Le An Pham
    PLOS ONE.2024; 19(6): e0306339.     CrossRef
  • Comprehensive Score for Financial Toxicity and Health-Related Quality of Life in Patients With Cancer and Survivors: A Systematic Review and Meta-Analysis
    Stevanus Pangestu, Fanni Rencz
    Value in Health.2023; 26(2): 300.     CrossRef
  • Association between financial toxicity and health-related quality of life of patients with gynecologic cancer
    Yusuke Kajimoto, Kazunori Honda, Shiro Suzuki, Masahiko Mori, Hirofumi Tsubouchi, Kohshiro Nakao, Anri Azuma, Takashi Shibutani, Shoji Nagao, Takahiro Koyanagi, Izumi Kohara, Shuko Tamaki, Midori Yabuki, Lida Teng, Keiichi Fujiwara, Ataru Igarashi
    International Journal of Clinical Oncology.2023; 28(3): 454.     CrossRef
  • Financial Toxicity Following Cancer in a Middle-Income Country with a Pluralistic Health System: Validation of the COST Questionnaire
    Veni V. Sakti, Mahmoud Danaee, Cheng-Har Yip, Ros S. A. Bustamam, Marniza Saad, Gin Gin Gan, Jerome Tan, Yueh Ni Lim, Flora L.T. Chong, Murallitharan Munisamy, Farahida Mohd Farid, Boon Lui Sew, Yek-Ching Kong, Nishalini Muniandy, Nirmala Bhoo-Pathy
    Cancer Care Research Online.2023; 3(3): e044.     CrossRef
  • Financial Toxicity Among Breast Cancer Patients
    Yi Kuang, Xiaoyi Yuan, Zheng Zhu, Weijie Xing
    Cancer Nursing.2023;[Epub]     CrossRef
  • Heterogeneity of financial toxicity and associated risk factors for older cancer survivors in China
    Mingzhu Su, Siqi Liu, Li Liu, Fang Wang, Jiahui Lao, Xiaojie Sun
    iScience.2023; 26(10): 107768.     CrossRef
  • Evaluation of financial toxicity and associated factors in female patients with breast cancer: a systematic review and meta-analysis
    Yusuf Çeli̇k, Sevilay Şenol Çeli̇k, Seda Sarıköse, Hande Nur Arslan
    Supportive Care in Cancer.2023;[Epub]     CrossRef
  • Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer
    Yusuke Kajimoto, Takashi Shibutani, Shoji Nagao, Satoshi Yamaguchi, Shiro Suzuki, Masahiko Mori, Hirofumi Tsubouchi, Kohshiro Nakao, Anri Azuma, Takahiro Koyanagi, Izumi Kohara, Shuko Tamaki, Midori Yabuki, Lida Teng, Kazunori Honda, Ataru Igarashi
    International Journal of Gynecologic Cancer.2022; : ijgc-2022-003410.     CrossRef
  • 7,319 View
  • 186 Download
  • 9 Web of Science
  • 11 Crossref
Close layer
Pediatric cancer
The Broad Variability in Dental Age Observed among Childhood Survivors Is Cancer Specific
Patrycja Proc, Joanna Szczepańska, Małgorzata Zubowska, Beata Zalewska-Szewczyk, Wojciech Młynarski
Cancer Res Treat. 2021;53(1):252-260.   Published online August 24, 2020
DOI: https://doi.org/10.4143/crt.2020.275
AbstractAbstract PDFPubReaderePub
Purpose
The study aimed to assess the differences in dental maturation between childhood cancer survivors and healthy children.
Materials and Methods
Fifty-nine cancer patients including 16 (27.1%) girls and 43 (72.8%) boys, aged between 4 and 16 years, underwent dental and radiographic examinations. The mean duration of anticancer therapy was 16.8 months (range, 1 to 47 months), and 4.6 years (range, 8 to 123 months) had passed since the termination of disease. The control group consisted of 177 panoramic radiographs of age- and sex-matched healthy individuals. Dental age (DA) was estimated with Demirjian’s scale and delta age, i.e., DA–chronological age (CA), was used to compare groups.
Results
The DA of cancer survivors was accelerated by almost 1 year compared to their CA (9.9±3.1 vs. 8.9±2.8, p=0.040). The greatest difference was observed among patients with brain tumor: delta (DA–CA) was 2.2±1.1 years. Among all cancer patients, only children with familial adenomatous polyposis (FAP)-associated hepatoblastoma (HP) demonstrated delayed DA, with regard to both other cancer survivors (p=0.011) and healthy patients (p=0.037). All four patients with HP suffered from FAP, and three of them had documented adenomatous polyposis coli (APC) genes mutation. The DA of cancer patients having teeth with short roots was significantly greater than that of the cancer survivors without this anomaly (12.8±3.2 vs. 9.0±2.4, p < 0.001).
Conclusion
DA in children may be altered by cancer disease.

Citations

Citations to this article as recorded by  
  • Dental management of long-term childhood cancer survivors: a systematic review
    K. Seremidi, S. Gizani, G. Dahllöf, M. Barr-Agholme, D. Kloukos, G. Tsilingaridis
    European Archives of Paediatric Dentistry.2024; 25(5): 611.     CrossRef
  • Dental age estimation in children that have undergone antineoplastic treatment
    A. Mitsea, K. Seremidi, A. Tsiligianni, S. Gizani
    European Archives of Paediatric Dentistry.2022; 23(2): 243.     CrossRef
  • Comparative Study of Malocclusions between Cancer Patients and Healthy Peers
    Patrycja Proc, Joanna Szczepanska, Anna Herud, Malgorzata Zubowska, Wojciech Fendler, Monika Lukomska-Szymanska, Wojciech Mlynarski
    International Journal of Environmental Research and Public Health.2022; 19(7): 4045.     CrossRef
  • 6,880 View
  • 104 Download
  • 3 Web of Science
  • 3 Crossref
Close layer
Outcomes of Pregnancy after Breast Cancer in Korean Women: A Large Cohort Study
Moo Hyun Lee, Young Ae Kim, Jin Hyuk Hong, So-Youn Jung, Sunmi Lee, Sun-Young Kong, Boyoung Park, Eun Sook Lee
Cancer Res Treat. 2020;52(2):426-437.   Published online September 3, 2019
DOI: https://doi.org/10.4143/crt.2018.382
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The purpose of this study was to determine the rate and outcomes of pregnancies subsequent to breast cancer in Korea, and the effect of such pregnancies on the prognosis of women who survived breast cancer and subsequently conceived. Materials and Methods We followed a total of 31,761 Korean women 45 years of age or younger who were treated for primary breast cancer from 2002 to 2010. We also included follow-up surveys that were conducted through December 2011. We identified recurrence and mortality from breast cancer using data linked to the Korea National Health Insurance database. We used propensity score matching of the study cohort to analyze the risks of recurrence and mortality from breast cancer depending on pregnancy.
Results
Within our sample, 992 women (3.1%) became pregnant after receiving treatment for breast cancer. Of those, 622 (67.5%) successfully delivered; the remaining 370 (32.5%) failed to deliver. After propensity score matching, we found that the women who became pregnant after breast cancer did not have a different risk of recurrence (hazard ratio [HR], 0.503; 95% confidence interval [CI], 0.434 to 0.584) and death (HR, 0.520; 95% CI, 0.397 to 0.681), compared with those who did not conceive after breast cancer treatment. Conclusion Our study is the first to report outcomes for Korean women who survived breast cancer and subsequently conceived. Women who survived breast cancer and subsequently became pregnant did not show a poorer survival outcome, compared with those who did not become pregnant.

Citations

Citations to this article as recorded by  
  • Conception and pregnancy among women with a live birth after breast cancer treatment: A survey study of young breast cancer survivors
    Kimia Sorouri, Tal Sella, Shoshana M. Rosenberg, Maggie Loucks, Gregory Kirkner, Craig Snow, Kathryn J. Ruddy, Shari I. Gelber, Rulla M. Tamimi, Jeffrey M. Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Ann H. Partridge
    Cancer.2024; 130(4): 517.     CrossRef
  • Safe and successful pregnancy following breast cancer treatment in young patients 35 years old or under without invasive fertility preservation: a retrospective study
    Ji Hye Kim, Yong Yeup Kim, Jai Hyun Chung, Woo Young Kim, Jae Bok Lee, Sang Uk Woo
    Annals of Surgical Treatment and Research.2024; 106(4): 189.     CrossRef
  • Female reproductive health in pediatric, adolescent, and young adult cancer survivors
    Holly R. Hoefgen, Janie Benoit, Serena Chan, Yasmin Jayasinghe, Maryam Lustberg, Victoria Pohl, Amanda Saraf, Deb Schmidt, Leslie Coker Appiah
    Pediatric Blood & Cancer.2023;[Epub]     CrossRef
  • Pregnancy rate, maternal and neonatal outcomes among breast cancer survivors: A systematic review
    Marzieh Azizi, Elham Ebrahimi, Zahra Behboodi Moghadam, Zohreh Shahhosseini, Maryam Modarres
    Nursing Open.2023; 10(10): 6690.     CrossRef
  • Breast Cancer in Pregnancy
    Natalie Levey, Iris Krishna
    Obstetrics and Gynecology Clinics of North America.2022; 49(1): 181.     CrossRef
  • Prognosis of pregnancy after breast cancer diagnosis according to the type of treatment: A population-based study in Korea by the SMARTSHIP group
    Soo Youn Bae, Jihyoun Lee, Ji Sung Lee, Jae Sun Yoon, Ku Sang Kim, Yoo Seok Kim, Zisun Kim, Jun Won Min, Eun-Jung Shim, Ilkyun Lee, Min Hyuk Lee, Sungmin Park
    The Breast.2022; 63: 46.     CrossRef
  • Update on Pregnancy Following Breast Cancer Diagnosis and Treatment
    Marta Perachino, Francesca Poggio, Luca Arecco, Eva Blondeaux, Stefano Spinaci, Camilla Marrocco, Alessia Levaggi, Matteo Lambertini
    The Cancer Journal.2022; 28(3): 176.     CrossRef
  • Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population‐based study
    J. Alejandro Rauh‐Hain, Jose Zubizarreta, Roni Nitecki, Alexander Melamed, Shuangshuang Fu, Kirsten Jorgensen, Paula C. Brady, Valerie L. Baker, Mariana Chavez‐MacGregor, Sharon H. Giordano, Nancy L. Keating
    Cancer.2022; 128(17): 3243.     CrossRef
  • Survival after breast cancer in women with a subsequent live birth: Influence of age at diagnosis and interval to subsequent pregnancy
    Richard A. Anderson, Matteo Lambertini, Peter S. Hall, W. Hamish Wallace, David S. Morrison, Tom W. Kelsey
    European Journal of Cancer.2022; 173: 113.     CrossRef
  • Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis
    Matteo Lambertini, Eva Blondeaux, Marco Bruzzone, Marta Perachino, Richard A. Anderson, Evandro de Azambuja, Philip D. Poorvu, Hee Jeong Kim, Cynthia Villarreal-Garza, Barbara Pistilli, Ines Vaz-Luis, Cristina Saura, Kathryn J. Ruddy, Maria Alice Franzoi,
    Journal of Clinical Oncology.2021; 39(29): 3293.     CrossRef
  • 7,519 View
  • 332 Download
  • 11 Web of Science
  • 10 Crossref
Close layer
Prevalence and Predictors of Sustained Smoking after a Cancer Diagnosis in Korean Men
Hye Yeon Koo, Kiheon Lee, Sang Min Park, Jooyoung Chang, Kyuwoong Kim, Seulggie Choi, Mi Hee Cho, Jihye Jun, Sung Min Kim
Cancer Res Treat. 2020;52(1):139-148.   Published online June 25, 2019
DOI: https://doi.org/10.4143/crt.2018.609
AbstractAbstract PDFPubReaderePub
Purpose
Although smoking has a significant impact on mortality and morbidity of cancer patients, many patients continue to smoke post-diagnosis. The purpose of this study was to investigate prevalence and predictors of sustained smoking among male cancer survivors.
Materials and Methods
The Korean National Health Insurance Service-National Health Screening Cohort database was used for this population-based, retrospective study. Study subjects were 15,141 men who were diagnosed with their first incident cancer between 2004 and 2011. Changes in smoking status before and after a cancer diagnosis were investigated. For patients who were current smokers pre-diagnosis, association between post-diagnosis sustained smoking and demographic, socioeconomic, and clinical variables were examined.
Results
Of the 4,657 pre-diagnosis smokers, 2,255 (48%) had quit after cancer diagnosis, while 2,402 (51.6%) continued to smoke. In a multivariate logistic regression analysis, younger age at cancer diagnosis (adjusted odds ratio [aOR], 1.37; 95% confidence interval [CI], 1.21 to 1.55; p < 0.001), low socioeconomic status (aOR, 1.29; 95% CI, 1.15 to 1.45; p ≤ 0.001), pre-diagnosis heavy smoking (aOR, 1.24; 95% CI, 1.09 to 1.41; p=0.001), diagnosis of non-smoking– related cancer (aOR, 1.67; 95% CI, 1.42 to 1.96; p < 0.001), and high serum glucose level (aOR, 1.23; 95% CI, 1.03 to 1.46; p=0.019) were associated with sustained smoking after a cancer diagnosis.
Conclusion
Almost half of the male smokers continue to smoke after a cancer diagnosis. Targeted interventions for smoking cessation should be considered for patients with younger age, low socioeconomic status, heavy smoking history, non-smoking–related cancer, and high blood glucose levels.

Citations

Citations to this article as recorded by  
  • Prevalence of Current Cigarette Smoking by Sociodemographic Characteristics in U.S. Cancer Survivors
    Liza M. González Ruiz, Lía I. Mondragón Márquez, Daniela L. Domínguez Bueso, Jason J. Liu
    Substance Use & Misuse.2024; 59(4): 486.     CrossRef
  • Healthy lifestyle and cancer survival: A multinational cohort study
    Zilong Bian, Rongqi Zhang, Shuai Yuan, Rong Fan, Lijuan Wang, Susanna C. Larsson, Evropi Theodoratou, Yimin Zhu, Shouling Wu, Yuan Ding, Xue Li
    International Journal of Cancer.2024; 154(10): 1709.     CrossRef
  • Smoking Cessation Support: A Marathon, Not a Sprint; The Perspectives of Cancer Patients Who Smoke
    Patricia Fox, Nancy Bhardwaj, Ailsa Lyons, Vikram Niranjan, Kate Frazer, Shiraz Syed, Amanda McCann, Sinead Brennan, Donal Brennan, Catherine Kelly, Michael Keane, Patricia Fitzpatrick
    Seminars in Oncology Nursing.2024; 40(2): 151584.     CrossRef
  • Association Between Cardiovascular Event Type and Smoking Cessation Rates Among Outpatients With Atherosclerotic Cardiovascular Disease: Insights From the NCDR PINNACLE Registry
    Vittal Hejjaji, Edward F. Ellerbeck, Philip G. Jones, Christina M. Pacheco, Ali O. Malik, Paul S. Chan, John A. Spertus, Suzanne V. Arnold
    Circulation: Cardiovascular Quality and Outcomes.2024;[Epub]     CrossRef
  • Determinants of persistent smoking among breast cancer survivors
    Kathleen Gali, Sita Aryal, Frederike Bokemeyer, Sabine Behrens, Petra Seibold, Nadia Obi, Heiko Becher, Jenny Chang-Claude
    Preventive Medicine Reports.2024; 48: 102913.     CrossRef
  • Factors associated with successful smoking cessation in men with or without cardiovascular disease or cancer: Nationwide Korean population analysis
    Youngmee Kim, Won-Kyung Cho
    Tobacco Induced Diseases.2023; 21(February): 1.     CrossRef
  • Mortality risk according to smoking trajectories after cancer diagnosis among Korean male cancer survivors: A population-based cohort study
    Thi Tra Bui, Minji Han, Ngoc Minh Luu, Thi Phuong Thao Tran, Sun Young Kim, Young Ae Kim, Min Kyung Lim, Jin-Kyoung Oh
    Tobacco Induced Diseases.2023; 21(May): 1.     CrossRef
  • Challenges posed by COVID‐19 in cancer patients: A narrative review
    Zeinab Mohseni Afshar, Rezvan Hosseinzadeh, Mohammad Barary, Soheil Ebrahimpour, Amirmasoud Alijanpour, Babak Sayad, Dariush Hosseinzadeh, Seyed Rouhollah Miri, Terence T. Sio, Mark J. M. Sullman, Kristin Carson‐Chahhoud, Arefeh Babazadeh
    Cancer Medicine.2022; 11(4): 1119.     CrossRef
  • Quitting Smoking At or Around Diagnosis Improves the Overall Survival of Lung Cancer Patients: A Systematic Review and Meta-Analysis
    Saverio Caini, Marco Del Riccio, Virginia Vettori, Vieri Scotti, Chiara Martinoli, Sara Raimondi, Giulio Cammarata, Domenico Palli, Marco Banini, Giovanna Masala, Sara Gandini
    Journal of Thoracic Oncology.2022; 17(5): 623.     CrossRef
  • Cessation experiences and quitting perspectives of Jordanian cancer patients who smoke
    Feras I. Hawari, Minas A. Abu Alhalawa, Rasha H. Alshrideh, Ahmad M. Al Nawaiseh, Alia Khamis, Yasmeen I. Dodin, Nour A. Obeidat
    Cancer Epidemiology.2022; 79: 102207.     CrossRef
  • Changes in cigarette smoking behavior among breast cancer and unaffected women – A prospective study in the MARIE cohort
    Kathleen Gali, Frederike Bokemeyer, Sabine Behrens, Annika Möhl, Nadia Obi, Heiko Becher, Jenny Chang-Claude
    Cancer Epidemiology.2022; 81: 102282.     CrossRef
  • Supporting Smokers in Difficult Settings: Suggestions for Better Education and Counseling in Cancer Centers in Jordan
    Feras I. Hawari, Minas A. Abu Alhalawa, Rasha H. Alshraiedeh, Ahmad M. Al Nawaiseh, Alia Khamis, Yasmeen I. Dodin, Nour A. Obeidat
    Current Oncology.2022; 29(12): 9335.     CrossRef
  • Efficacy of an inpatient smoking cessation program at a single regional cancer center
    Ha-Young Park, Yu-Ri Choe, In-Jae Oh, Min-Seok Kim, Bo Gun Kho, Hong-Joon Shin, Cheol Kyu Park, Yu-Il Kim, Young-Chul Kim, Hye-Ran Ahn, Sun-Seog Kweon
    Medicine.2021; 100(6): e24745.     CrossRef
  • Smoking Cessation in Cancer Survivors
    Young Gyu Cho
    Korean Journal of Family Medicine.2021; 42(4): 258.     CrossRef
  • Impact of Family and Social Network on Tobacco Cessation Amongst Cancer Patients
    Melissa Neumann, Neal Murphy, Nagashree Seetharamu
    Cancer Control.2021;[Epub]     CrossRef
  • 6,535 View
  • 188 Download
  • 16 Web of Science
  • 15 Crossref
Close layer
Health-Related Quality of Life, Perceived Social Support, and Depression in Disease-Free Survivors Who Underwent Curative Surgery Only for Prostate, Kidney and Bladder Cancer: Comparison among Survivors and with the General Population
Dong Wook Shin, Hyun Sik Park, Sang Hyub Lee, Seung Hyun Jeon, Seok Cho, Seok Ho Kang, Seung Chol Park, Jong Hyock Park, Jinsung Park
Cancer Res Treat. 2019;51(1):289-299.   Published online May 4, 2018
DOI: https://doi.org/10.4143/crt.2018.053
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study was to compare health-related quality of life (HRQoL) of disease-free prostate (PC), kidney (KC), and bladder cancer (BC) survivors with that of the general population.
Materials and Methods
Our study included 331 urological cancer (UC) survivors (114 PC, 108 KC, and 109 BC) aged ≥ 50 years disease-free for at least 1 year after surgery. The control group included 1,177 subjects without a history of cancer. The HRQoL was assessed using the European Organization for Research and Treatment of Cancer QLQ-C30, the Duke-UNC Functional Social Support Questionnaire, and the Patient Health Questionnaire-9.
Results
There was no significant difference between the groups in terms of any of the functioning sub-scales and symptoms, except significantly lower social functioning observed in BC survivors than that observed in KC survivors. Although the three groups of UC survivors showed essentially similar functioning sub-scales and symptoms when compared to the general population, PC and BC survivors showed significantly lower social functioning and a lower appetite than that observed in controls. KC survivors showed lower physical functioning, as well as higher pain and dyspnea. Although all three groups of UC survivors reported higher financial difficulties, they also reported higher perceived social support than that reported by the non-cancer control group. No statistically significant difference was observed in terms of depressive symptoms between each group of UC survivors and the general population.
Conclusion
Disease-free survivors of the three major types of UCs showed generally similar HRQoL compared to the general population, as well as compared to each other.

Citations

Citations to this article as recorded by  
  • Role performance and factors affecting quality of life in bladder cancer survivors with ileal orthotopic neobladder
    So Hee Kim, Eunjung Ryu, Byong Chang Jeong
    Asia-Pacific Journal of Oncology Nursing.2024; 11(6): 100490.     CrossRef
  • The mental and emotional status after radical cystectomy and different urinary diversion orthotopic bladder substitution versus external urinary diversion after radical cystectomy: A propensity score‐matched study
    Giuseppe Palermo, Francesco Pio Bizzarri, Eros Scarciglia, Emilio Sacco, Koosha Moosavi Seyed, Pierluigi Russo, Filippo Gavi, Battista Filomena Giovanni, Francesco Rossi, Marco Campetella, Angelo Totaro, Nazario Foschi, Marco Racioppi
    International Journal of Urology.2024; 31(12): 1423.     CrossRef
  • Factors Affecting the Health-Related Quality of Life of Patients with Bladder Cancer
    Haetsal Kwon, Hyojung Park
    Journal of Korean Public Health Nursing.2024; 38(3): 358.     CrossRef
  • Properties of the Shift and Persist Questionnaire in adolescent and young adult cancer patients and survivors: Validity, consistency, and interpretability
    Karly M. Murphy, Edith Chen, Edward H. Ip, Abby R. Rosenberg, Mallory A. Snyder, John M. Salsman
    Quality of Life Research.2023; 32(1): 273.     CrossRef
  • Adoption of patient communication rules in clinical practice and the role of faith-based communities in shaping them: the palliative aspect of spiritual support
    Konstantin Sokolovskiy, Olga Pashanova, Vladimir Beketov, Andrey Aleshkin
    Mental Health, Religion & Culture.2023; 26(1): 16.     CrossRef
  • Identifying the unmet supportive care needs of people affected by kidney cancer: a systematic review
    Amy O’Dea, Craig Gedye, Belinda Jago, Catherine Paterson
    Journal of Cancer Survivorship.2022; 16(6): 1279.     CrossRef
  • Mental Health in Urologic Oncology
    Danyon Anderson, Abrahim N. Razzak, Matthew McDonald, David Cao, Jamal Hasoon, Omar Viswanath, Alan D. Kaye, Ivan Urits
    Health Psychology Research.2022;[Epub]     CrossRef
  • Psychological Distress in Patients Treated for Renal Cell Carcinoma: A Systematic Literature Review
    Liliana Vartolomei, Manuela Schmidinger, Mihai Vartolomei, Shahrokh Shariat
    Journal of Clinical Medicine.2022; 11(21): 6383.     CrossRef
  • Health-Related Quality of Life among Cancer Survivors Depending on the Occupational Status
    Kisook Kim, Hyohyeon Yoon
    International Journal of Environmental Research and Public Health.2021; 18(7): 3803.     CrossRef
  • Feasibility of a socio-spiritual intervention to improve quality of life of adult Nigerians with cancer and their family caregivers: Protocol for a randomised controlled trial
    Israel Gabriel, Debra Creedy, Elisabeth Coyne
    Contemporary Clinical Trials Communications.2021; 22: 100802.     CrossRef
  • Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls—results from a population-based study
    Salome Adam, Daniela Doege, Lena Koch-Gallenkamp, Melissa S. Y. Thong, Heike Bertram, Andrea Eberle, Bernd Holleczek, Ron Pritzkuleit, Mechthild Waldeyer-Sauerland, Annika Waldmann, Sylke Ruth Zeissig, Lina Jansen, Sabine Rohrmann, Hermann Brenner, Volker
    Supportive Care in Cancer.2020; 28(6): 2875.     CrossRef
  • Comorbid depression in medical diseases
    Stefan M. Gold, Ole Köhler-Forsberg, Rona Moss-Morris, Anja Mehnert, J. Jaime Miranda, Monika Bullinger, Andrew Steptoe, Mary A. Whooley, Christian Otte
    Nature Reviews Disease Primers.2020;[Epub]     CrossRef
  • Health-related Quality of Life and Its Related Factors among Cancer Survivors and General Adults: Focusing on Lifestyle Behaviors and Mental Health
    Eun A Song, Youngran Kweon, Yoon Young Hwang, Minjeong An
    Korean Journal of Adult Nursing.2020; 32(4): 385.     CrossRef
  • Age and gender differences in anxiety and depression in cancer patients compared with the general population
    Andreas Hinz, Philipp Yorck Herzberg, Florian Lordick, Joachim Weis, Hermann Faller, Elmar Brähler, Martin Härter, Karl Wegscheider, Kristina Geue, Anja Mehnert
    European Journal of Cancer Care.2019;[Epub]     CrossRef
  • 12,188 View
  • 216 Download
  • 12 Web of Science
  • 14 Crossref
Close layer
Psychosocial Health of Disease-Free Breast Cancer Survivors Compared with Matched Non-cancer Controls
Boyoung Park, Moo Hyun Lee, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat. 2019;51(1):178-186.   Published online April 5, 2018
DOI: https://doi.org/10.4143/crt.2017.585
AbstractAbstract PDFPubReaderePub
Purpose
The present study investigated the psychosocial health of disease-free breast cancer survivors who receive health examinations compared to matched non-cancer controls in a community setting.
Materials and Methods
We used baseline data from the Health Examinee cohort, which is composed of subjects participating in health. The disease-free breast cancer survivors were defined as those who were ≥ 2 years from initial diagnosis of breast cancer who had completed treatment. Females without a history of cancer were randomly selected at 1:4 ratio by 5-year age groups, education, and household income as a comparison group. We analyzed results from the Psychosocial Well-being Index-Short Form (PWI-SF) as a psychosocial health measurement.
Results
A total of 347 survivors of breast cancer and 1,388 matched controls were included. Total scores on the PWI-SF were lower in breast cancer survivors than matched non-cancer controls (p=0.006), suggesting a lower level of psychosocial stress in breast cancer survivors. In comparison to the control group, prevalence of drinking, smoking and obesity were lower, while exercising for ≥ 150 min/wk was higher in breast cancer survivors (p < 0.05). These findings suggest that breast cancer survivors have better health behaviors than their noncancer controls. After adjusting for other sociodemographic variables, breast cancer survivors were 36% less likely to be included in the stress group (odds ratio, 0.64; 95% confidence interval, 0.42 to 0.98).
Conclusion
The disease-free breast cancer survivors resuming daily life demonstrated better psychosocial health status compared to matched non-cancer controls.

Citations

Citations to this article as recorded by  
  • Effect of perceived injustice-targeted pain neuroscience education compared with biomedically focused education in breast cancer survivors: a study protocol for a multicentre randomised controlled trial (BCS-PI trial)
    Eva Roose, Eva Huysmans, Laurence Leysen, Kenza Mostaqim, Paul Van Wilgen, David Beckwée, Marijke De Couck, Annick Timmermans, Rinske Bults, Jo Nijs, Astrid Lahousse
    BMJ Open.2024; 14(1): e075779.     CrossRef
  • Effects of a Single Session of Mindfulness and Compassion on Skin Temperature in Breast Cancer Survivors
    David A. Rodríguez, Nadia Martínez, Li Erandi Tepepa Flores, Benjamín Domínguez, Patricia Cortés, Ana L. Chávez
    International Journal of Environmental Research and Public Health.2024; 21(8): 1064.     CrossRef
  • Gender Difference in the Impact of Total Energy Intake on the Association between Low Fiber Intake and Mental Health in Middle-Aged and Older Adults
    Sinyoung Cho, Minseon Park
    Nutrients.2024; 16(16): 2583.     CrossRef
  • Psychological factors influencing healthcare utilization in breast cancer survivors with pain
    Eva Roose, Wilfried Cools, Laurence Leysen, Paul Van Wilgen, David Beckwée, Annick Timmermans, Rinske Bults, Jo Nijs, Marian Vanhoeij, Christel Fontaine, Astrid Lahousse, Eva Huysmans
    Pain Medicine.2024; 25(12): 768.     CrossRef
  • Determinants of Psychosocial Distress in Breast Cancer Patients at a Safety Net Hospital
    Jessica K. Liu, Amy H. Kaji, Katherine G. Roth, Danielle M. Hari, James J. Yeh, Christine Dauphine, Junko Ozao-Choy, Kathryn T. Chen
    Clinical Breast Cancer.2022; 22(1): 43.     CrossRef
  • Self-Concept and Psychosocial Well-Being among Korean Women with BRCA1/2 Gene Mutations
    Kyunghwa Lee, Doo Ree Kim
    Asian Oncology Nursing.2022; 22(1): 11.     CrossRef
  • Psychosocial stress accompanied by an unhealthy eating behavior is associated with abdominal obesity in Korean adults: A community-based prospective cohort study
    Minji Kim, Yangha Kim
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Effect of Psychosocial Distress on the Rate of Kidney Function Decline
    Jae Young Kim, Young Su Joo, Jong Hyun Jhee, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang, Jung Tak Park
    Journal of General Internal Medicine.2021; 36(10): 2966.     CrossRef
  • Signifikanter Überlebensvorteil durch Sacituzumab-Govitecan beim TNBC
    Sebastian Weiße, Svenja Quaester, Jürgen Dunst
    InFo Hämatologie + Onkologie.2021; 24(9): 29.     CrossRef
  • 7,466 View
  • 149 Download
  • 7 Web of Science
  • 9 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP